May 29, 2020
News in Brief

News in Brief, May 2020

April 15, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, March/April 2020

Seamless patient mangement during the pandemic; COVID-19 Virtual Town Hall for Community Physicians and Research Staff; remembering Dr. Uma Rao; recognizing the John H. Stroger, Jr. Hospital of Cook County Minority Underserved NCORP; spotlight on the EROS trial, which is evaluating a program to help women with cancer and their physicians plan for reproductive health and preservation of sexuality during and after cancer treatment
April 15, 2020
Patient in office

Now Enrolling: EA1181 Decreasing Chemotherapy in HER2 Positive Breast Cancer

For patients who have a pathologic complete response (pCR) after 12 weeks of pre-operative THP (single agent taxane plus trastuzumab and pertuzumab), is it safe to omit additional therapy after surgery?
April 15, 2020
Patient skin exam

Now Enrolling: EA6183 Evaluating Encorafenib and Binimetinib in Metastatic Melanoma

A single-arm phase II trial evaluating the effectiveness of treatment before surgery with encorafenib and binimetinib
April 15, 2020
Brain fog image

Trial Results: TAILORx Cognition Data in JCO and EA1141 Brief MRI vs 3-D in JAMA

April 15, 2020

Remembering Uma Rao, MD

April 15, 2020

Institution Spotlight: John H. Stroger, Jr. Hospital of Cook County Minority Underserved NCI Community Oncology Research Program

A Standing Main Member of ECOG-ACRIN since 2002
April 15, 2020

Trial Spotlight: E1Q11 / EROS For Female Cancer-Diagnosed Patients with Reproductive Health Goals

A one-of-a-kind cancer care delivery research trial that offers young women with cancer an assessment of their goals for fertility and family planning to make the most of cancer treatment and preserve future reproductive health
February 28, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, February 2020

January meeting with NCI leaders and the Cooperative Group Chairs; Congress increases NCI and overall NIH budget for FY 2020; EA opens two new trials, one for pancreatic cyst monitoring (EA2185) and the other to evaluate nivolumab in head and neck cancer (EA3161); plans are underway for the next Comis Symposium
February 28, 2020

Now Enrolling: EA2185 to Compare the Clinical Impact of Pancreatic Cyst Surveillance Programs

This trial is comparing two common surveillance methods in people with at least one non-cancerous cyst in the pancreas, to measure which one leads to better outcomes. The study may also uncover findings that could predict the behavior of these cysts.
February 28, 2020

Social Media and Clinical Trials

Mike Thompson writes that educating and engaging the public--both via social media and in person--is necessary to sustain a national clinical trials infrastructure and continue advancing cancer research
February 28, 2020
News in Brief

News in Brief, February 2020